Notice of Intent to Publish a Funding Opportunity Announcement for Research Evaluation and Commercialization Hubs (REACH) program

Grants.Gov Federal grants application process

Opportunity ID:310845
Opportunity Number:NOT-OD-19-033
Opportunity Title:Notice of Intent to Publish a Funding Opportunity Announcement for Research Evaluation and Commercialization Hubs (REACH) program
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Grant
Category of Funding Activity:Health
Category Explanation:
CFDA Number(s):
Eligible Applicants:Public and State controlled institutions of higher education
Private institutions of higher education
Additional Information on Eligibility:
Agency Code:HHS-NIH11
Agency Name:Department of Health and Human Services
National Institutes of Health
Posted Date:Dec 04, 2018
Last Updated Date:Dec 04, 2018
Estimated Synopsis Post Date:Dec 15, 2018
Fiscal Year:2019
Award Ceiling:$1,000,000
Award Floor:
Estimated Total Program Funding:$1,000,000
Expected Number of Awards:5
Description:The National Institutes of Health (NIH) intends to publish a Funding Opportunity Announcement (FOA) to establish 5 new awards for the Research Evaluation and Commercialization Hubs (REACH) program to address the problems that hinder the critical, early steps necessary to translate novel scientific advances and discoveries into commercially viable diagnostics, devices, therapeutics, and tools that improve patient care and advance public health. The five awardees will participate in a technology development consortium that incorporates best practices from current pilot programs and fulfills the objectives of the Phase 0 Proof of Concept Partnership pilot program, in accordance with Section 5127 of the 2011 SBIR/STTR Reauthorization Act (P.L. 112-81) and reauthorized through FY 2022 within H.R. 5515 Sec 854. The REACH program advances FY2020 Administration Research and Development Budget Priorities, including educating and training a workforce for the 21st century economy, transferring technology from the laboratory to the marketplace, and partnering with industry and academia to advance the R&D enterprise. The REACH program will not support hypothesis-driven, basic science research. Rather, the REACH hubs will nurture the development of early-stage technologies that address high priority areas of unmet medical by (1) scouting for promising biomedical projects; (2) conducting scientific and business reviews by life science experts; (3) funding projects with up to $200,000 (50% federal funds and 50% matching funds) and providing industry-experienced project managers; (4) delivering product development and entrepreneurship training catalyzing professional development; and (5) developing, strengthening and promoting sustainable partnerships with industry and the private sector such as accelerators/incubators, and other sources of private funding and intellectual capital required to accelerate technology transfer and development. In addition, the hubs are expected to leverage and partner with existing NIH or other federal resources and non-federal resources such as EDA’s Regional Innovation Strategies (RIS) Program i6 Challenge, NSF Innovation Corps (I-Corps™), SBA Growth Accelerators, NCI-designated Cancer Centers, NIAID Centers for AIDS Research (CFAR), NCATS Clinical and Translational Science Awards (CTSA), NIBIB’s Concept to Clinic: Commercializing Innovation Program (C3i) and Point-of-Care Technologies Research Network (POCTRN); NIGMS’ Regional Technology Transfer Accelerator Hubs for IDeA States, IDeA Networks of Biomedical Research Excellence (INBRE), and Centers of Biomedical Research Excellence (COBRE); current NIH Centers for Accelerated Innovations (NCAI) and REACH, and the Coulter Translational Partnership Award in Biomedical Engineering (TP). Funding for each project is tied to milestones that advance the technology toward a viable product, facilitating an innovative succeed (or fail) fast model that is nimbler than traditional grant funding models. During development, the hubs will also provide access to resources for marketing, business strategy, regulatory planning, and identifying strategic partners and investors. Hands-on educational activities, including entrepreneurial education programs and coaching by seasoned industry veterans is intended to improve the ability of innovators to develop their business plans and pitch their technologies to investors to attract partners for continued development following their period of federal support. The program is intended to create cultural and systemic changes by providing the necessary resources to proactively and rapidly move from breakthrough innovations to products that will have health, economic, and societal impact. This Notice is provided to allow prospective applicants time to consider the REACH Program and develop essential collaborations and plans prior to submitting an application in response to the published FOA. The FOA is expected to be published in the NIH Guide for Grants and Contracts in December 2018 with an expected application due date in March 2019. The FOA will utilize the U01 funding mechanism, which is a cooperative agreement that requires significant interaction between the awardees and the NIH staff.

Visit the Official Webpage For More Details on Notice of Intent to Publish a Funding Opportunity Announcement for Research Evaluation and Commercialization Hubs (REACH) program